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journal homepage: http : / /www.europsy- journal .comThe use of smartphone based data streams in relation to mental
health research is steadily gaining traction in the ﬁeld [1]. This
approach, also known as digital phenotyping, yields continuous
behavioural data which shows promise in uncovering new
perspectives on human behaviour [2]. However, calls have recently
been addressing the need for increased awareness regarding the
privacy of the participants [3]. These concerns coincide with the
new European General Data Protection Regulation (GDPR) that came
into effect 25 May 2018 [4]. In most cases, the GDPR will
fundamentally impact how research should go about handling
highly sensitive (medical) data, since the GDPR comes with some
new responsibilities and obligations for both controllers1 and
processors2. One of these obligations requires organisations to
carry out a Data Protection Impact Assessment (DPIA). This article
will assess the impact of such a DPIA on research in practice
1. About the GDPR
The road to compliance with the GDPR proves to be a
challenging path for small scale and tech-driven research
initiatives. First, limitations regarding technical and legal knowl-
edge gaps need to be overcome. Second, being a technology driven
initiative, proper security standards need to be met and main-
tained in order to ensure that participant data is handled
responsibly. This calls for an interdisciplinary approach to research
projects operating in this space. Thereby drawing from various
additional specialisations, such as biology, law and informatics.
The GDPR lays down the rules relating to the protection of
personal data, which is deﬁned as “any information relating to an
identiﬁed or identiﬁable natural person”. Although the GDPR
speciﬁcally mentions that identiﬁcation can take place via
identiﬁers such as name, identiﬁcation number and location data,
identiﬁcation is not limited to these identiﬁers. The GDRP does not
only set out rules for dealing with personal data, it also offers a tool
that can help to implement mandatory practices as laid out in the
GDPR: a Data Protection Impact Assessment.1 The controller determines what data is collected, how this is done and for which
purpose (article 4(7) GDPR).
2 Processors never determine the purpose and means of data processing, they
merely process the data collected by the controller on behalf of the controller and
under the instructions of the controller (article 4(8) GDPR).
http://dx.doi.org/10.1016/j.eurpsy.2018.07.003
0924-9338/© 2018 Elsevier Masson SAS. All rights reserved.2. Data protection impact assessment
Research data management concerns different stages, namely
preparation, data collection, data processing, data analysis, data
preservation, access to data and publication and re-use. Since a
DPIA helps to visualise the impact of the intended data processing,
the DPIA should take place at the end of the preparation phase, or
the beginning of the data collection phase. A DPIA is not always
mandatory, however, in many instances carrying out a DPIA is still
advisable since it will help to both build and demonstrate
compliance with the GDPR [7]. For example, a DPIA might help
to comply with the requirements of data protection by design and
by default.
The GDPR does not deﬁne the concept of a DPIA in detail, but
sets a number of minimum requirements instead. These
minimum requirements, such as an assessment of the
necessity and proportionality of the processing operations in
relation to the purposes, result in the situation where both the
content of the assessment and the way in which a DPIA is
carried out is left to the discretion of the controller. The
advisory body known as the European Data Protection Board
(EDPB) and previously known as the Article 29 Working Party
specify that the controller can choose the methodology, as long
as the methodology is compliant with the criteria provided in
their guidelines.
Concerning the question of when a DPIA is obligated, the GDPR
gives some general guidelines. For example, if new technologies
are used and the processing is ‘likely to result in a high risk to the
rights and freedoms of natural persons’ the controller is obliged to
carry out a DPIA before the processing starts. The term ‘new
technologies’ is not deﬁned by the GDPR, but is described by the
recitals of the GDPR as ‘in accordance with the achieved state of
technological knowledge’. Furthermore, three situations in which a
DPIA has to be carried out are described in paragraph 3 of article 35
GDPR. Although these three situations are meant as a non-
exhaustive list, it does offer some support to the controller if a
decision has to be made whether or not a DPIA is needed.
Paragraph 8 of article 35 GDPR mentions that if codes of conduct
are in place, compliance to these codes have to be taken into
account, in particular for the purpose of a DPIA. Therefore,
researchers could really beneﬁt from the development of such a
(European) code of conduct.
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Scientiﬁc research is, by nature, innovative and therefore often
inclined to push the existing limits of knowledge. As a result, for
studies requiring the use of personal data, a DPIA is most probably
needed and can enhance transparency. This article uses the BEHAPP
programme as introduced next, as an example to show how the GDPR,
focussed on the DPIA, affects digital phenotyping research in practice.
4. BEHAPP
The BEHAPP programme is centred around the use of passively
collected smartphone data to help quantify human behaviour in
terms of communication and exploration [5]. The supporting
software, BEHAPP V2, has been developed by the University of
Groningen (Faculty of Science & Engineering), a non-proﬁt
academic organisation. One of the major design goals of BEHAPP
V2 is that it is built as a research platform allowing for multiple
simultaneous and conﬁgurable studies. This has resulted in various
initiatives that are currently employing BEHAPP in their respective
lines of research helping to evaluate clinical relevance of digital
phenotyping tools in practice. For example, BEHAPP is imple-
mented to identify novel digital biomarkers for social withdrawal
in patients suffering from schizophrenia, Alzheimer’s disease, and
Major Depression in the PRISM study [6], a large EU funded
Innovative Medicine Initiative project. In the BEHAPP programme
scientists from the Faculty of Science and Engineering work closely
together with, among others, scientists from the Faculty of Law.
This interdisciplinary approach has proven helpful in light of the
GDPR in general and a DPIA speciﬁcally.
In this case, the BEHAPP working context is especially interesting,
since the programme is both the producer of the app and a joint
controller of the data collection. In the latter case this means that
article 26 GDPR applies, since that article deals with the situation of
joint controllers. Article 26 GDPR determines that joint controllers
have to determine their respective responsibilities in a transparent
matter. In the case of BEHAPP, the consortium agreement or the data
management plan could be used for this. On the other hand, the
privacy statement of the app should also make notice of the situation
of joint controllers. Since participants are furthermore divided in
several groups, for example focus groups and patient groups, this
impacts the question of transparency.
For BEHAPP awareness of the GDPR comes at a relatively late
stage with the service already in active use by different studies.
Nonetheless, the initiative is currently going through its ﬁrst DPIA
cycle and based on the initial review, BEHAPP is now expanding
and improving on its policies detailing privacy and information
security. Transparency is key and depending on who will be using
the service (e.g. Schizophrenia patients or healthy controls)
different tailor made documents have to be developed to secure
understanding of data use by the participant.
Furthermore, the design reﬂects principles taken from concepts
such as data protection by design and by default. For example,
participant records are pseudonymised through a practice also
known as coding so participants can only be referred to through a
unique identiﬁer and no directly identiﬁable information is stored
in the system, with the exception of location data, which is collected
as part of the measurements taken by the smartphone application.
Lastly, since privacy protection is a continuous process, going
forward in line with GDPR this means that efforts must continue to
improve data protection. The GDPR demands technical and
organisational measures are taken to ensure data protection.
From a technical perspective this is established by applying
increased isolation measures on sensitive data and by applying
encryption. From an organisational perspective researchers are
trained on responsible use and handling of sensitive data.5. Concluding the cycle
In the case of BEHAPP, this DPIA is a ﬁrst-time experience for all
parties involved. It has shown that an interdisciplinary approach is
essential to responsibly create and operate a tech-driven research
initiative. A DPIA can help bring deﬁciencies to light which
otherwise may not have surfaced. The cycle enforces all parties to
continuously remain critical on technical developments while
aligning these efforts to data protection frameworks like the GDPR.
At the same time it is important to remain mindful of the (often)
limited capacity of small scale and tech-driven research initiatives.
This is why we plead for a (European) code of conduct, which could
really beneﬁt researchers.
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